View all newsletters
Sign up for our free email newsletters

Fighting for quality news media in the digital age.

  1. Media Law
January 7, 2013

Lance Armstrong ‘could admit to doping claims’ as Sunday Times sues for £1m

By Andrew Pugh

Disgraced cyclist Lance Armstrong is reportedly considering publicly admitting to using performance-enhancing drugs, as he faces a £1m legal action from The Sunday Times.

Armstrong was last year accused of being the ringleader of the “most sophisticated, professionalised and successful doping programme that sport has ever seen” by the United States Anti-Doping Agency (USADA).

Despite a mass of evidence indicating Armstrong’s use of performance-enhancing drugs and blood transfusions, which saw him stripped of his seven Tour de France titles, the cyclist has denied any wrongdoing.

A report in the New York Times on Friday  quoted several unnamed sources suggesting Armstrong could now admit to doping offences in a bid to “restore his eligibility so he can resume his athletic career”.

While backers of Armstrong’s Livestrong charity were said to have put pressure on Armstrong to confess, the NYT notes that “several legal cases stand in the way of a confession”.

Among them is a case being pursued by The Sunday Times’ publisher News International.

The company reached an out-of-court settlement understood to have cost around £600,000 in 2006 over an article linking Armstrong with allegations of doping.  

Content from our partners
MHP Group's 30 To Watch awards for young journalists open for entries
How PA Media is helping newspapers make the digital transition
Publishing on the open web is broken, how generative AI could help fix it

The paper recently confirmed that it had issued proceedings against Armstrong over his libel action.

The Sunday Times is demanding a return of the settlement payment plus interest, as well as its costs in defending the case, with the total claim likely to exceed £1m.

A letter sent to Armstrong’s lawyers stated: “It is clear that the proceedings were baseless and fraudulent. Your representations that you had never taken performance enhancing drugs were deliberately false.”

Topics in this article : ,

Email pged@pressgazette.co.uk to point out mistakes, provide story tips or send in a letter for publication on our "Letters Page" blog

Select and enter your email address Weekly insight into the big strategic issues affecting the future of the news industry. Essential reading for media leaders every Thursday. Your morning brew of news about the world of news from Press Gazette and elsewhere in the media. Sent at around 10am UK time. Our weekly does of strategic insight about the future of news media aimed at US readers. A fortnightly update from the front-line of news and advertising. Aimed at marketers and those involved in the advertising industry.
  • Business owner/co-owner
  • CEO
  • COO
  • CFO
  • CTO
  • Chairperson
  • Non-Exec Director
  • Other C-Suite
  • Managing Director
  • President/Partner
  • Senior Executive/SVP or Corporate VP or equivalent
  • Director or equivalent
  • Group or Senior Manager
  • Head of Department/Function
  • Manager
  • Non-manager
  • Retired
  • Other
Visit our privacy Policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
Thank you

Thanks for subscribing.

Websites in our network